The @NCATS Alliance hosted our first ever reception last night in Bethesda, MD with @NCATS @Director, Dr. Joni Rutter and her amazing senior team. It was a wonderful gathering to celebrate the incredible science being advanced by NCATS as we work to build awareness and support for translational science, gene therapies, drug repurposing, and big data initiatives, to name a few. It was great to see Ron Bartek, Annie Kennedy, Paul Melmeyer, June Cha, PhD, MPH, Tasnuva Khan and many others who joined us for the first of many Alliance receptions with our NCATS colleagues. #ncats #genetherapies #raredisease #clinicaltrials #translationalscience #n3c
关于我们
The NCATS Alliance seeks to support the National Center for Advancing Translational Sciences (NCATS), a center within the National Institutes of Health, transform and accelerate translational sciences research and development so as to provide more treatments for rare and common diseases to more patients more quickly. The NCATS Alliance aims to do this by: 1. Securing sustained appropriations and policies necessary to further enable NCATS to lead the transformation and acceleration of translational science research and development; and 2. Educating policymakers, medical professionals, the medical industry, patients, and other stakeholders about the nature and vital role of NCATS in translational sciences research and development in improving our health and well-being.
- 网站
-
https://ncatsalliance.org/
NCATS Alliance的外部链接
- 所属行业
- 非盈利组织
- 规模
- 1 人
- 类型
- 非营利机构
- 领域
- Translational Sciences、Rare Diseases、Advocacy and Education、Research、Life Sciences、Public Policy、Biopharmaceuticals、Gene Therapy和Clinical Data
动态
-
The NCATS Alliance hosted our first annual Advocacy Day on Capitol Hill last week and met with congressional and committee staff to build support for federal investments in rare disease research, gene therapy/editing, translational science, clinical trials, and expansion of open science, real world data platforms. #ncats #TranslationalScience #CTSAProgram #ClinicalTrials #RareDiseases #nih #GeneEditing #DrugRepurposing #research
-
-
The NCATS Alliance is pleased to share the @National Center for Advancing Translational Sciences’ draft strategic plan. We encourage all interested stakeholders to provide comment on the plan by the June 14 deadline. The plan is a vital roadmap that will support NCATS’ mission of turning research observations into health solutions through #TranslationalScience.? https://lnkd.in/e9e27VKk
-
The NCATS Alliance is proud to share our letter to the House and Senate Appropriations committee leadership recommending that Congress allocate at least $51.303 billion for the National Institutes of Health #NIH and no less than $1.194 billion for the National Center for Advancing Translational Sciences #NCATS as part of the Fiscal Year 2025 Labor, Health and Human Services and Education Appropriations legislation.?The Alliance represents the voice of the life sciences and data logistics industry, patient advocacy organizations, including rare disease groups, academic research institutions, and non-profit thought leaders and innovators with a shared goal of advancing translational science to catalyze the development of new diagnostics and therapies to detect and treat a wide range of human disease.?Please join us in urging #Congress to fund critical science to improve the lives of millions of Americans living with common and rare diseases.??#NCATS #NIH #raredisease #science #research
-
The NCATS Alliance toured the #NCATS labs today and met with NCATS Director Dr. Joni Rutter and her scientific team who are advancing translational, data, and related science to improve the lives of Americans living with common and rare diseases and conditions. #nih #ncats #research #rarediseases #genetherapy #ai #robotics #translationalresearch #clinicalresearch
-
-
As we embark on our second year of working together to support the critical mission of National Center for Advancing Translational Sciences (NCATS), we are pleased to announce Kevin Brennan of Bluebird Strategies has been named by the Board of Directors as Executive Director of the NCATS Alliance.?Kevin has several decades of success leading policy, advocacy, and political initiatives in senior roles in Congress, the biopharmaceutical industry, and the patient advocacy field.?Under Kevin’s leadership, the NCATS Alliance is eager to advance our mission of educating policymakers on the importance of translational science and advocating for the necessary federal resources and policies to accelerate the development of new #diagnostics and #therapies to detect and treat a wide range of human disease.?